|
AVXL Anavex Life Sciences Corp 1314052 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-5,681,000.00 |
| Balance Sheet |
|
Assets
|
$132,989,000.00 |
|
Liabilities
|
$6,371,000.00 |
|
Equity
|
$126,618,000.00 |
|
Shares Out
|
92671758.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,151,000.00 |
| Market Analysis |
Market Cap
|
$250,213,746.60 |
|
Price
|
$2.79 |
|
BVPS
|
1.37 |
|
PB
|
1.97 |
|
EPS
|
-0.06 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-09 |
-0.06 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.16 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-25 |
-0.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVXL documents filed with the SEC.
AVXL Filings
Clear
